Cubist Systematic Strategies, LLC Atri Cure, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$28.21 - $37.78 $1.71 Million - $2.28 Million	-60,470 Reduced 28.34%	152,931 $4.65 Million
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $4.31 Million - $5.65 Million	130,522 Added 157.49%	213,401 $7.62 Million
Q3 2023 Nov 14, 2023	SELL	$41.12 - $57.73 $2.13 Million - $2.99 Million	-51,798 Reduced 38.46%	82,879 $3.63 Million
Q2 2023 Aug 14, 2023	BUY	$40.44 - $49.6 $961,137 - $1.18 Million	23,767 Added 21.43%	134,677 $6.65 Million
Q1 2023 May 15, 2023	BUY	$35.87 - $47.22 $1.94 Million - $2.55 Million	54,074 Added 95.14%	110,910 $4.6 Million
Q4 2022 Feb 14, 2023	BUY	$33.48 - $47.45 $339,554 - $481,237	10,142 Added 21.72%	56,836 $2.52 Million
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $617,546 - $849,549	16,145 Added 52.85%	46,694 $1.83 Million
Q2 2022 Aug 15, 2022	BUY	$35.1 - $66.01 $935,204 - $1.76 Million	26,644 Added 682.3%	30,549 $1.25 Million
Q1 2022 May 16, 2022	SELL	$57.43 - $71.39 $777,257 - $966,192	-13,534 Reduced 77.61%	3,905 $256,000
Q4 2021 Feb 14, 2022	BUY	$63.4 - $87.14 $783,180 - $1.08 Million	12,353 Added 242.88%	17,439 $1.21 Million
Q3 2021 Nov 15, 2021	SELL	$69.28 - $84.46 $374,181 - $456,168	-5,401 Reduced 51.5%	5,086 $354,000
Q2 2021 Aug 16, 2021	BUY	$64.13 - $80.18 $672,531 - $840,847	10,487 New	10,487 $832,000
Q1 2021 May 17, 2021	SELL	$53.79 - $66.98 $704,917 - $877,772	-13,105 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$34.56 - $57.55 $452,908 - $754,192	13,105 New	13,105 $730,000
Q3 2020 Nov 16, 2020	SELL	$38.36 - $46.91 $1.13 Million - $1.39 Million	-29,551 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$31.78 - $51.19 $644,085 - $1.04 Million	20,267 Added 218.3%	29,551 $1.33 Million
Q1 2020 May 15, 2020	BUY	$24.49 - $43.84 $150,589 - $269,572	6,149 Added 196.14%	9,284 $312,000
Q4 2019 Feb 14, 2020	SELL	$24.06 - $32.51 $293,868 - $397,077	-12,214 Reduced 79.58%	3,135 $102,000
Q3 2019 Nov 14, 2019	BUY	$23.81 - $32.52 $365,459 - $499,149	15,349 New	15,349 $383,000
Q4 2018 Feb 14, 2019	SELL	$26.66 - $34.85 $11,223 - $14,671	-421 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$27.62 - $35.58 $11,628 - $14,979	421 New	421 $15,000
Q4 2017 Feb 14, 2018	SELL	$17.69 - $23.44 $52,380 - $69,405	-2,961 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$20.0 - $24.23 $59,220 - $71,745	2,961	2,961 $66,000

Others Institutions Holding ATRC

# of Institutions

212

Shares Held

49.6M

Call Options Held

12K

Put Options Held

7.2K

Vanguard Group Inc Valley Forge, PA

4.66M
Shares

$189 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.62M
Shares

$187 Million
0.0% of portfolio
Alliancebernstein L.P. New York, NY

3.97M
Shares

$161 Million
0.04% of portfolio
Hood River Capital Management LLC Palm Beach Gardens, FL

2.83M
Shares

$115 Million
1.47% of portfolio
Champlain Investment Partners, LLC Burlington, VT

2.79M
Shares

$113 Million
0.5% of portfolio

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.88B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account